Single Cell Technologies Applicable to Atopic Eczema

At ESDR 2022 | September 28, 2022, 13:00 - 16:30 (1:00 - 4:30 PM) CEST | 7:00 -10:30 AM EDT 

Beurs Van Berlage, Room 3 of Graanbeurszaal Hall | Amsterdam, the Netherlands   

Join the IEC for a special symposium addressing the Single Cell Technologies Applicable to Atopic Eczema.  This symposium will take place prior to the European Society for Dermatological Research (ESDR) annual meeting. Learn more about the ESDR 51st Annual meeting.    

Watch On-Demand Webcasts

PROGRAM CHAIRS

Nick Reynolds, MD, FRCP
Newcastle University | Newcastle-Upon-Tyne, UK

Emma Guttman, MD, PhD
Icahn School of Medicine at Mount Sinai | New York, New York, USA

AGENDA

13:00 – 13:10 CEST Welcome from the IEC | A virtual introduction | Robert Bissonnette, MD, FRCP; IEC President | Innovaderm Research | Montreal, QC, Canada

13:10 – 13:20 CEST Program Overview | Nick Reynolds, MD, FRCP & Emma Guttman, MD, PhD

13:20 – 13:50 CEST Single Cell Genomics Technologies: an Overview (virtual pre-recorded lecture) | Professor Muzlifah Haniffa, FMedSci | Newcastle University / Sanger Institute | Newcastle-upon-Tyne / Cambridge, UK

13:50 – 14:20 CEST Contribution of Fibroblasts to the Pathogenesis of AD | Helen He, MD | Icahn School of Medicine at Mount Sinai | New York, NY

14:20 – 14:50 CEST The Technology of Spatial Transcriptomics from a Clinical Standpoint | Andrew Ji, MD | Icahn School of Medicine at Mount Sinai | New York, NY USA

14:50 – 15:05 CEST BREAK

15:05 – 15:35 CEST Spatial Transcriptomics Applicable to AD | Stefanie Eyerich, PhD | Helmholtz Zentrum München | Neuherberg, Germany

15:35 – 16:05 CEST New Minimally Invasive Techniques for Biomarker Discovery | Emma Guttman, MD, PhD | Icahn School of Medicine at Mount Sinai | New York, NY USA

16:05 – 16:30 CEST Panel Discussion | All Presenters | Moderator: Nick Reynolds, MD, FRCP & Emma Guttman, MD, PhD

This educational symposium presented by the IEC is offered at no cost to attendees.

HEALTH AND SAFETY TRAVEL RESOURCES

IEC will comply with local mandates at the time of the in-person meeting.